NDC 55289-217

ERY-TAB

Erythromycin

ERY-TAB is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, In. The primary component is Erythromycin.

Product ID55289-217_7bc03715-edf4-a6bd-e053-2991aa0a5d04
NDC55289-217
Product TypeHuman Prescription Drug
Proprietary NameERY-TAB
Generic NameErythromycin
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2011-04-18
Marketing CategoryANDA / ANDA
Application NumberANDA062298
Labeler NamePD-Rx Pharmaceuticals, In
Substance NameERYTHROMYCIN
Active Ingredient Strength500 mg/1
Pharm ClassesDecreased Sebac
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 55289-217-28

28 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-217-28)
Marketing Start Date2011-12-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55289-217-28 [55289021728]

ERY-TAB TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA062298
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-12-21

NDC 55289-217-40 [55289021740]

ERY-TAB TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA062298
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-12-21

Drug Details

Active Ingredients

IngredientStrength
ERYTHROMYCIN500 mg/1

OpenFDA Data

SPL SET ID:3acbc324-9a11-4e48-b5ad-b4cc3b38dd48
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 206080
  • 310157
    • UPC Code
  • 0355289217282

    • Pharmacological Class

    • Decreased Sebaceous Gland Activity [PE]
    • Macrolide [EPC]
    • Macrolide Antimicrobial [EPC]
    • Macrolides [CS]
    • Decreased Sebaceous Gland Activity [PE]
    • Macrolide [EPC]
    • Macrolide Antimicrobial [EPC]
    • Macrolides [CS]

    NDC Crossover Matching brand name "ERY-TAB" or generic name "Erythromycin"

    NDCBrand NameGeneric Name
    21695-457ERY-TABerythromycin
    24338-122ERY-TABErythromycin
    24338-124ERY-TABErythromycin
    68151-1170ERY-TABERY-TAB
    68151-1174ERY-TABERY-TAB
    24338-126ERY-TABERY-TAB
    43063-569ERY-TABERY-TAB
    50090-0339ERY-TABERY-TAB
    55289-217ERY-TABERY-TAB
    55289-525ERY-TABERY-TAB
    0378-8075ERYGELerythromycin
    0093-5571ErythromycinErythromycin
    0093-5572ErythromycinErythromycin
    0168-0215Erythromycinerythromycin
    0168-0216Erythromycinerythromycin
    0378-8212Erythromycinerythromycin
    0404-7191ErythromycinErythromycin
    0574-4024erythromycinerythromycin
    13668-586ERYTHROMYCINERYTHROMYCIN
    13668-588ERYTHROMYCINERYTHROMYCIN
    13668-606ErythromycinErythromycin
    13668-607ErythromycinErythromycin
    13985-605ErythromycinErythromycin
    17478-070ErythromycinErythromycin
    17478-824ErythromycinErythromycin
    21695-173ErythromycinErythromycin
    24208-910ErythromycinErythromycin
    24338-102ErythromycinErythromycin
    24338-104ErythromycinErythromycin
    24338-120ERYTHROMYCINErythromycin
    21695-387ERYTHROMYCIN Base FilmtabERYTHROMYCIN
    21695-389ERYTHROMYCIN Base FilmtabERYTHROMYCIN

    Trademark Results [ERY-TAB]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ERY-TAB
    ERY-TAB
    73286993 1211217 Live/Registered
    Abbott Laboratories
    1980-11-21
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.